-

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080222950

Enrollment

120

Registered

2015-08-31

Start date

2015-09-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

investigational material(s) Generic name etc : - INN of investigational material : palbociclib Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational mate

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

Measure	Time frame
efficacy -	—

Secondary

Measure	Time frame
efficacy pharmacokinetics safety -	—

Countries

Asia except Japan, Europe, Japan, North America, South America

Outcome results